Eve & Co Inc V.EVE.H

RE:RE:Private Placement - Special Warrants - May 10, 2019

[CleverInvestor2]

Here's one of corvettes aliases. Eve didn't buy their own shares for 10M (50cents each). A rich MM/company did because they did their own DD and saw value in the long term. If anyone is wearing the rose glasses, it's the guy who bought 10M worth of shares... So again, why are you hear purposely scaring people to sell with falsehoods? Do you have nothing better to do in life? What's your end goal? Why are you here wasting your time on something you think is garbage? If I think ACB is garbage, I won't invest in them nor waste hours upon hours everyday critizing them and lying.

parthent wrote:

WinterBaron wrote: Investors in EVE can either accept that those with greater inside information about the company than ordinary shareholders and accordingly
1.)made responsible decisions to provide this special financing 
or
2.)They can live in a world where they believe their opinions without all of the facts have more worth.

If you fall into group 2, then why are you still hanging around this bullboard?
Why not just move on to where your opinion and investment has greater value for you?

I choose to accept that EVE like most of the industry in the U.S. and Canada is going through serious growing pains.
However, this company has positioned itself well to financially and physically progress strongly as the industry evolves internationally.
How long is it going to take for the industry to get it's health in order?
I don't know, but my sense is that Health Canada is recognizing it has been instrumental in creating what some would describe as a "Shambles" during this 1st year of legalization and province's like Ontario are accepting similar responsibility.

My guess is:
In the next couple of months a number of positive regulatory adjustments, licencing issues and tax/pricing matters will be settled and allow licenced producers to operate their businesses without all the disadvantages now faced against illegal growers and other market competive products such as alcohol.  


Private Placement of Special Warrants On May 10, 2019 (the ‘Closing”),
the Company completed the private placement of special warrants comprised of 20,900,000 special warrants of the Company (the “Special Warrants”), at a price of $0.50 per Special Warrant for aggregate gross proceeds of $10,450,000 (the “Special Warrant Offering”).

Each Special Warrant is exercisable into one (1) unit of the Company (a “Unit”), for no additional consideration, at any time after the Closing, and each Special Warrant not previously exercised shall be deemed exercised on the earlier of (i) the fifth business day after a receipt is issued for a final prospectus qualifying the Units for distribution in all of the Canadian provinces in which purchasers reside, except Qubec (the “Qualifying Jurisdictions”) and (ii) September 11, 2019.

Each Unit consists of one (1) Common Share and one Common Share purchase warrant (a “2019 Warrant”).
Each 2019 Warrant entitles the holder thereof to purchase one Common Share (a “2019 Warrant Share”) at an exercise price of $0.60 until May 10, 2021.

The Company has received approval to list the Common Shares, 2019 Warrants and 2019 Warrant Shares on the TSXV.
In consideration for their services, the underwriter received a cash commission equal to 7% of the gross proceeds of the Special Warrant Offering of $731,500 and was issued 1,463,000 compensation special warrants (“Compensation Special Warrants”) equal to 7% of the number of Special Warrants sold in the Special Warrant Offering.

Each Compensation Special Warrant is exercisable into one (1) compensation option (a “2019 Compensation Option”), for no additional consideration, at any time after the Closing,
and each Compensation Special Warrant not previously exercised is deemed exercised on the earlier of (i) the fifth business day after a receipt is issued for a final prospectus qualifying the Units for distribution in Qualifying Jurisdictions and (ii) September 11, 2019.

Each 2019 Compensation Option entitles the holder thereof to purchase one Common Share at an exercise price of $0.50 until May 10, 2021.

You must be wearing the same prescription eye glasses as Mel R. ROSE COLOURED. Its time for an eye test my friend. Youre obviously seeing things IF you see potential with this management. Good luck you're gonna need it!